ACRV

Acrivon Therapeutics, Inc.

NasdaqGM · Healthcare

$1.86

+4.49% today

last filing 2026-05-18Pro sees filings in ~15 min

Price

hover · 4 moves explained

3 buys12 8-K

Analyst consensus

Strong Buy

$11.50target+518.3%vs $1.86 today

$7.00 low today target$19.00 high

6 analysts · ~12-month consensus · as of May 28. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 3 of last 4

Earnings per share · actual vs forecast

Q2 '25+5.7%

−$0.55

exp −$0.58

Q3 '25+19.0%

−$0.47

exp −$0.58

Q4 '25-7.4%

−$0.49

exp −$0.46

Q1 '26+5.8%

−$0.49

exp −$0.52

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-05-20	RA CAPITAL MANAGEMENT, L.P.	10% owner	—Indirect	9,366	—	—
Grant	2026-05-20	TOMSICEK MICHAEL JOHN	Director	—Direct	9,366	—	—
Grant	2026-05-20	Shacham Sharon	Director	—Direct	9,366	—	—
Grant	2026-05-20	Palani Santhosh	Director	—Direct	9,366	—	—
Grant	2026-05-20	Magovcevic-Liebisch Ivana	Director	—Direct	9,366	—	—

Grant

RA CAPITAL MANAGEMENT, L.P.

10% owner · 2026-05-20

—

9,366 shares

Grant

TOMSICEK MICHAEL JOHN

Director · 2026-05-20

—

9,366 shares

Grant

Shacham Sharon

Director · 2026-05-20

—

9,366 shares

Grant

Palani Santhosh

Director · 2026-05-20

—

9,366 shares

Grant

Magovcevic-Liebisch Ivana

Director · 2026-05-20

—

9,366 shares

45 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →